台股 » 個股 » 英濟 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

英濟

(3294)
可現股當沖
  • 股價
    30.35
  • 漲跌
    ▲0.15
  • 漲幅
    +0.50%
  • 成交量
    421
  • 產業
    上櫃 電子零組件類股
  • 93人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
英濟 (3294)籌碼相關-富邦-大墩 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-大墩 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/04/261036.1500.0035.30106,7170.15%
2024/04/24337.8700.0037.2536,6590.05%
2024/04/22135.5000.0035.0016,5740.02%
2024/04/1900.00137.0036.75-16,511-0.02%
2024/04/18240.9800.0038.5526,4130.03%
2024/04/173240.533840.3340.70-66,335-0.09%
2024/04/162538.67438.8339.95216,2450.34%
2024/04/15341.30740.8740.60-46,125-0.07%
2024/04/12248.9500.0044.6525,9390.03%
2024/04/11248.60248.0548.8505,7580.00%
2024/04/1010451.669850.0050.5065,6150.11% 大買/
2024/04/09248.90648.5749.90-45,242-0.08%
2024/04/0800.00246.0045.40-24,897-0.04%
2024/04/02443.2500.0042.4044,6720.09%
2024/03/29247.40249.3346.5004,4940.00%
2024/03/2800.00845.2145.15-84,318-0.19%
2024/03/26143.60344.0043.45-24,100-0.05%
2024/03/253944.041844.3544.35213,9900.53%
2024/03/21140.9000.0040.9513,4210.03%
2024/03/2000.00142.3041.20-13,371-0.03%
2024/03/197.540.95541.5040.702.53,2650.08%
2024/03/185243.724143.7943.50113,1590.35%
2024/03/14139.90140.0539.3002,5880.00%
2024/03/13542.17140.6041.5042,4670.16%
2024/03/12544.22445.0544.6512,3150.04%
2024/03/112.545.50347.2245.50-0.52,175-0.02%
2024/03/0800.00147.5547.20-11,988-0.05%
2024/03/07552.400.552.8052.404.51,8180.25%
2024/03/0600.00258.1058.20-21,435-0.14%
2024/03/0400.00153.3054.50-11,384-0.07%
2024/02/27154.9000.0058.5011,2770.08%
2024/02/26153.5000.0056.6011,2510.08%
2024/02/23151.3000.0051.5011,2270.08%
2024/02/22147.6000.0050.0011,2120.08%
2024/02/2100.00248.7049.80-21,173-0.17%
2024/02/1900.001.341.6245.50-1.31,080-0.12%
2024/02/1600.001.241.2542.15-1.21,034-0.11%
2024/02/1518.540.0500.0041.5018.59781.89%
2024/02/051837.30637.9238.30128231.46%
2024/02/02234.2500.0034.8526910.29%
2024/02/01131.702031.7031.70-19593-3.20%
2024/01/3100.00128.8528.85-1379-0.26%
2024/01/291023.90123.9023.9093392.65%
2024/01/1800.00118.3518.35-1266-0.38%
2024/01/1600.00218.8318.75-2292-0.68%
2023/12/2500.00118.8518.50-1306-0.33%
2023/12/180.219.4000.0019.300.23450.04%
2023/12/1100.00119.3019.30-1333-0.30%
2023/12/0400.00119.3519.30-1338-0.30%
2023/11/1500.00219.1019.00-2335-0.60%
2023/11/1400.00718.7719.00-7335-2.08%
2023/11/1300.00218.8318.75-2339-0.59%
2023/11/10319.3500.0019.3033440.87%
2023/11/08119.7500.0019.7513760.27%
2023/11/07119.95519.8519.75-4376-1.06%
2023/11/06520.1000.0020.0553781.32%
2023/11/0100.00519.8519.85-5369-1.35%
2023/10/3000.00320.2520.25-3355-0.84%
2023/10/27319.95420.1620.20-1342-0.29%
2023/10/26319.8500.0019.8533330.90%
2023/10/2500.00319.8519.75-3319-0.94%
2023/10/2300.00319.3019.15-3295-1.02%
2023/10/20318.9000.0019.0532941.02%
2023/10/18318.9000.0019.0532911.03%
2023/10/17519.1000.0019.0552881.73%
2023/09/27919.77919.4118.8002960.00%
2023/09/250.118.70318.7018.70-2.9257-1.14%
2023/09/2000.005.218.7018.55-5.2271-1.92%
2023/09/13319.1500.0018.8032911.03%
2023/09/06118.9000.0018.8013150.32%
2023/09/04318.5000.0018.7033190.94%
2023/08/22118.85518.6018.90-4374-1.07%
2023/08/17118.4500.0018.4513790.26%
2023/08/1500.001718.6918.50-17373-4.55%
2023/08/14318.5300.0018.5533730.80%
2023/07/27117.9500.0017.9514140.24%
2023/07/2000.00117.9517.95-1641-0.16%
2023/07/100.218.4000.0018.250.26760.02%
2023/07/05219.0000.0019.0027090.28%
2023/07/03319.2000.0019.0537130.42%
2023/06/2700.00019.0018.7007190.00%
2023/06/210.219.0000.0019.100.28240.02%
2023/06/13119.30319.2818.85-2880-0.23%
2023/06/12119.0000.0019.0018650.12%
2023/06/06818.7600.0018.5588700.92%
2023/06/05519.0100.0018.8058650.58%
2023/06/01818.8400.0018.8088550.94%
2023/05/3000.00118.3018.35-1827-0.12%
2023/05/18118.0000.0017.9017800.13%
2023/05/10018.4000.0017.9507230.00%
2023/05/08018.6500.0018.4007140.00%
2023/05/02019.30019.0518.8007190.00%
2023/04/28018.80118.7019.05-1707-0.14%
2023/04/27118.3000.0018.2516860.15%
2023/04/26619.1600.0018.4066770.89%
2023/04/25119.7000.0019.2016350.16%
〈焦點股〉益得攜英濟開發複方吸入劑 逆勢攻上漲停Anue鉅亨-2023/04/25
英濟拿下益得複方吸入劑給藥設備訂單 生醫事業添動能Anue鉅亨-2023/04/24
英濟 相關文章